In the field of Gynecology, ONJ is relevant primarily due to the use of certain medications for managing conditions like osteoporosis and breast cancer. Women undergoing treatment for these conditions are often prescribed bisphosphonates or denosumab, which have been linked to an increased risk of developing ONJ.
